Ben Tre Pharmaceutical JSC (HOSE:DBT)

Vietnam · Delayed Price · Currency is VND

13,000

0.00 (0.00%)

At close: Oct 13, 2026

Market Cap	285.57B +13.0%
Revenue (ttm)	873.41B +1.2%
Net Income	26.97B +71.5%
EPS	1,227.52 +78.2%
Shares Out	21.97M
PE Ratio	10.59
Forward PE	n/a
Dividend	801.81 (6.17%)
Ex-Dividend Date	n/a

Volume	710
Open	12,300
Previous Close	n/a
Day's Range	12,300 - 13,000
52-Week Range	9,990 - 13,900
Beta	0.27
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant... [Read more]

Industry Pharmaceutical Preparations

Founded 1963

Employees 614

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DBT

Full Company Profile

Financial Performance

In 2025, HOSE:DBT's revenue was 860.31 billion, a decrease of -0.93% compared to the previous year's 868.41 billion. Earnings were 12.85 billion, a decrease of -2.66%.

Financial Statements